MétaCan
Menu
← Back to cohort
Record W2586504507 · doi:10.1093/ecco-jcc/jjx002.377

P252 Elevated C-reactive protein level during clinical remission can predict poor outcomes in patients Crohn's disease

2017· article· en· W2586504507 on OpenAlexaboutno aff
Kyunghwan Oh, Eun Hye Oh, Eun Mi Song, Gyu-Hyung Kim, Myeongsook Seo, Sangwon Hwang, S.H. Park, Dagan Yang, K.-J. Kim, J.-S. Byeon, Seung‐Jae Myung, S K Yang, B.D. Ye

Bibliographic record

VenueJournal of Crohn s and Colitis · 2017
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsnot available
Fundersnot available
KeywordsCrohn's diseaseC-reactive proteinMedicineInternal medicineDiseaseGastroenterologyImmunologyInflammation

Abstract

fetched live from OpenAlex

Background: Intestinal mucosal damage in Crohn's disease (CD) is believed to progress even in patients showing clinical remission. We aimed to investigate the difference in the long-term prognosis of CD patients in clinical remission depending on serum C-reactive protein (CRP) levels during clinical remission. Methods: A total of 339 CD patients in clinical remission (defined by Crohn's disease activity index less than 150) for more than 6 months between January 2008 and December 2010 were enrolled in this study. Clinical outcomes represented by CD-related hospitalization, intestinal resection, perianal surgery, intestinal complications, and step-up of medical therapy were compared between normal CRP group and elevated CRP group during clinical remission. Results: There were 150 patients with normal CRP through 6 months of clinical remission and 189 patients who showed elevated CRP at least once during 6 months of clinical remission. During follow-up (median, 7.9 years [interquartile range, 6.8–8.0]), the Kaplan-Meier analysis with the log-rank test showed the superiority of the normal CRP group compared with the elevated CRP group in terms of CD-related hospitalization-free survival (Figure 1A, p=0.007) and intestinal resection-free survival (Figure 1B, p=0.046). Figure 1. Kaplan-Meier hospitalization-free survival curves (A) and intestinal resection-free survival curves (B). In multivariate analysis, elevated CRP and Montreal penetrating behavior were associated with increased risk of CD-related hospitalization (adjusted hazard ratio [aHR] 1.787; 95% confidence interval [CI] 1.245–2.565, p=0.002, and aHR 2.175; 95% CI 1.489–3.177, p<0.001, respectively). In addition, elevated CRP, Montreal structuring behavior, Montreal penetrating behavior, and use of immunomodulators were associated with increased risk of intestinal resection (aHR 1.726; 95% CI 1.003–2.969, p=0.049, aHR 2.722; 95% CI 1.223–6.058, p=0.014, aHR 4.149; 95% CI 2.117–7.907, p<0.001, and aHR 2.147; 95% CI 1.076–4.284, p=0.030, respectively). Conclusions: Even if patients with CD are in clinical remission, elevated CRP showed a significant association with poor prognosis represented by a higher risk of subsequent CD-related hospitalization and intestinal resection. More vigilant monitoring and therapeutic strategy are required for CD patients in remission, but with high CRP to improve long-term prognosis.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.005

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.288
Teacher spread0.272 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Crohn s and Colitis→Same topicInflammatory Bowel Disease→French-language works237,207→